Skip to content

EyePoint, Inc. EYPT Deferred Taxes

Deferred Taxes at other companies

Merck & Co. logo
Merck & Co.MRK
-$315M-69.4%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$3M-61.9%
United Therapeutics logo
United TherapeuticsUTHR
$25.9M

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:DeferredIncomeTaxExpenseBenefit.

The official record: EyePoint, Inc. ’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's deferred taxes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's deferred taxes?
EyePoint, Inc. (EYPT) reported deferred taxes of $369K in Q4 2025.
How has EyePoint, Inc. 's deferred taxes changed year-over-year?
EyePoint, Inc. 's deferred taxes increased by 310.0% year-over-year, from $90K to $369K.
What is the long-term trend for EyePoint, Inc. 's deferred taxes?
Over 2 years (2023 to 2025), EyePoint, Inc. 's deferred taxes has grown at a 163.9% compound annual growth rate (CAGR), from $83K to $578.25K.
What does deferred taxes mean?
Non-cash deferred tax expense or benefit representing the change in deferred tax assets/liabilities during the period.